Phase I Study Of Continuous Mkc-1 (Cmkc-1) In Patients (Pts) With Advanced Or Metastatic Solid Malignancies Using A Modified Time-To-Event Continual Reassessment Method (Tite-Crm) For Dose Assignment.
JOURNAL OF CLINICAL ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要